Literature DB >> 6726255

Measurement of acetylcholine turnover rate in brain: an adjunct to a simple HPLC method for choline and acetylcholine.

P E Potter, M Hadjiconstantinou, J L Meek, N H Neff.   

Abstract

An existing method for measuring acetylcholine (ACh) and choline (Ch) is shown to be useful for measuring the turnover rate of ACh in mouse brain. Methyl-[3H]Ch is injected into mice. They are killed at different times by microwave irradiation and Ch and ACh extracted and separated by reverse-phase HPLC. Ch and ACh are converted to hydrogen peroxide by a post-column enzyme reaction. Hydrogen peroxide, which is directly related to the tissue content of Ch or ACh, is determined electrochemically. The fractions that correspond to the detector response for Ch and ACh are collected for the measurement of radioactivity. In this way specific radioactivities of endogenous Ch and ACh are estimated in the same sample. We used the specific radioactivity values determined by this procedure to estimate the turnover of ACh for striatum, cerebral cortex, and hippocampus of the mouse.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726255     DOI: 10.1111/j.1471-4159.1984.tb06712.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  3 in total

1.  Effect of oxotremorine, physostigmine, and scopolamine on brain acetylcholine synthesis: a study using HPLC.

Authors:  N Bertrand; A Beley
Journal:  Neurochem Res       Date:  1990-11       Impact factor: 3.996

2.  Time course of decline of radiolabeled acetylcholine formed following intracerebroventricular administration of tritiated choline: effects of oxotremorine and scopolamine.

Authors:  N Bertrand; J Bralet; A Beley
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

Review 3.  Alzheimer's disease: Targeting the Cholinergic System.

Authors:  Talita H Ferreira-Vieira; Isabella M Guimaraes; Flavia R Silva; Fabiola M Ribeiro
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.